Health Minister Dr. Harsh Vardhan said that India’s COVID-19 vaccine-Covaxin- is likely to be made available to the general people by the end of this year after completion of trials. He also iterated that the Oxford vaccine is being manufactured on a parallel.
Talking to the media, Vardhan said the Serum Institute of India had informed that it was ready to start human trials in India this month and was hoping to have the AstraZeneca vaccine ready by the year-end. The ZyCoV-D from Zydus Cadila might complete its clinical trials in a couple of months he added.
India’s Covid-19 cases have went past 28 lakh with a record single-day spike of 69,652 infections, as per data from the Union Health Ministry. He said that it is difficult to predict when the peak would come in India in the advent of fresh cases dwindling.
Dr. Vardhan also added that the outbreak was likely to peak at different points in different cities and states. It depends on a variety of measures like implementation of policies, including the proportion of people taking preventive steps. He said all these factors make it difficult to predict when a drop in new cases would take place in the country.
Experts across the globe have said that only after the introduction of a vaccine the world would go back to normal. Vardhan said that vaccine trials globally are being expedited and the nation would also have one very soon.
The human trials of ‘COVAXIN’, developed by Hyderabad-based pharmaceutical firm Bharat Biotech, had already started two weeks back and could be available by the end of 2020.